Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL648778 | 1.00 | CNR2 (0.70) | CNR2 | |
| SCHEMBL649517 | 1.00 | CNR2 (0.70) | CNR2 | |
| SCHEMBL29825458 | 1.00 | CNR2 (0.70) | CNR2 | |
| SCHEMBL15396893 | 1.00 | CNR2 (0.70) | CNR2 | |
| SCHEMBL30256039 | 0.86 | CNR2 (0.77) | CNR2 | |
| SCHEMBL10979463 | 0.86 | CNR2 (0.77) | CNR2 | |
| SCHEMBL19327397 | 0.86 | CNR2 (0.77) | CNR2 | |
| SCHEMBL19327392 | 0.86 | CNR2 (0.77) | CNR2 | |
| SCHEMBL646716 | 0.83 | CNR2 (0.63) | CNR2 | |
| SCHEMBL10709155 | 0.83 | CNR2 (0.63) | CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2726447-B1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL | FIRMENICH & CIE (CH) | 2015-08-12 | — | — | EP | disclosed |
| EP-2726447-B1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL | FIRMENICH & CIE (CH) | 2015-08-12 | — | — | EP | disclosed |
| US-9056826-B2 | Process for the preparation of beta-santalol | FIRMENICH SA (CH) | 2015-06-16 | — | — | US | disclosed |
| US-9056826-B2 | Process for the preparation of beta-santalol | FIRMENICH SA (CH) | 2015-06-16 | — | — | US | disclosed |
| US-9056826-B2 | Process for the preparation of beta-santalol | FIRMENICH SA (CH) | 2015-06-16 | — | — | US | disclosed |
| US-8822733-B2 | Intermediates for the preparation of beta-santalol | FIRMENICH SA (CH) | 2014-09-02 | — | — | US | disclosed |
| US-8822733-B2 | Intermediates for the preparation of beta-santalol | FIRMENICH SA (CH) | 2014-09-02 | — | — | US | disclosed |
| US-20140213818-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL | FIRMENICH SA (CH) | 2014-07-31 | — | — | US | disclosed |
| US-20140213818-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL | FIRMENICH SA (CH) | 2014-07-31 | — | — | US | disclosed |
| US-20140213818-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL | FIRMENICH SA (CH) | 2014-07-31 | — | — | US | disclosed |
| US-20130310609-A1 | INTERMEDIATES FOR THE PREPARATION OF BETA-SANTALOL | FIRMENICH SA (CH) | 2013-11-21 | — | — | US | disclosed |
| EP-2386537-B1 | Intermediates for the preparation of beta-santalol and derivatives thereof | FIRMENICH & CIE (CH) | 2013-01-16 | — | — | EP | disclosed |
| WO-2013001026-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL | FIRMENICH SA (CH) | 2013-01-03 | — | — | WO | disclosed |
| EP-2386537-A2 | Intermediates for the preparation of beta-santalol and derivatives thereof | FIRMENICH SA (CH) | 2011-11-16 | — | — | EP | disclosed |
| US-20110254473-A1 | ARRANGEMENT AND METHOD FOR CONTROLLING FREQUENCY CONVERTER MODULES | ABB OY (FI) | 2011-10-20 | — | — | US | disclosed |
| EP-2282985-B1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | FIRMENICH & CIE (CH) | 2011-10-05 | — | — | EP | disclosed |
| US-7902393-B2 | Process for the preparation of β-santalol and derivatives thereof | FIRMENICH SA (CH) | 2011-03-08 | — | — | US | disclosed |
| EP-2282985-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | Firmenich SA (CH) | 2011-02-16 | — | — | EP | disclosed |
| US-20110028750-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | FIRMENICH SA (CH) | 2011-02-03 | — | — | US | disclosed |
| WO-2009141781-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | FIRMENICH SA (CH) | 2009-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140213818-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL | ACSL3, ACSL1, CSNK1A1L | CNR2 618/4885 |
| US-20110028750-A1 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF | SQLE, EBP, CYP17A1 | CNR2 937/4885 |
| US-20130310609-A1 | INTERMEDIATES FOR THE PREPARATION OF BETA-SANTALOL | RB1, EBP, XIAP | CNR2 3796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.